Downregulation of Fas ligand (FasL, CD95L) expression on T cells: A novel mechanism for preventing spontaneous and adoptive transfer of IDDM

被引：0
|
作者：
Singh, B
Zechel, M
Chaturvedi, P
Qin, HY
机构：
来源：
DIABETES | 1998年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
859
引用
收藏
页码：A222 / A222
页数：1
相关论文
共 50 条
  • [21] Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity
    Medana, I
    Li, ZX
    Flügel, A
    Tschopp, J
    Wekerle, H
    Neumann, H
    JOURNAL OF IMMUNOLOGY, 2001, 167 (02): : 674 - 681
  • [22] IL-2 induces Fas ligand Fas (CD95L/CD95) cytotoxicity in CD8(+) and CD4(+) T lymphocyte clones
    Esser, MT
    Dinglasan, RD
    Krishnamurthy, B
    Gullo, CA
    Graham, MB
    Braciale, VL
    JOURNAL OF IMMUNOLOGY, 1997, 158 (12): : 5612 - 5618
  • [23] Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival
    Neuber, Karsten
    Eidam, Bettina
    ONKOLOGIE, 2006, 29 (8-9): : 361 - 365
  • [24] Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation
    Lu, LN
    Qian, SG
    Hershberger, PA
    Rudert, WA
    Lynch, DH
    Thomson, AW
    JOURNAL OF IMMUNOLOGY, 1997, 158 (12): : 5676 - 5684
  • [25] CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
    Guegan, Jean-Philippe
    Pollet, Justine
    Ginestier, Christophe
    Charafe-Jauffret, Emmanuelle
    Peter, Marcus E.
    Legembre, Patrick
    ISCIENCE, 2021, 24 (12)
  • [26] Characterization of CD95/CD95L expression and apoptosis in T cells of patients with renal carcinoma (RCC)
    Kolenko, V
    Uzzo, RG
    Clark, PE
    Rayman, P
    Bukowski, R
    Tubbs, R
    Novick, AC
    Finke, JH
    JOURNAL OF UROLOGY, 1998, 159 (05): : 172 - 172
  • [27] Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration
    Bechmann, I
    Lossau, S
    Steiner, B
    Mor, G
    Gimsa, U
    Nitsch, R
    GLIA, 2000, 32 (01) : 25 - 41
  • [28] Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy
    Aoki, K
    Akyürek, LM
    San, H
    Leung, K
    Parmacek, MS
    Nabel, EG
    Nabel, GJ
    MOLECULAR THERAPY, 2000, 1 (06) : 555 - 565
  • [29] Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters
    Bayraktaroglu, T.
    Boztepe, H.
    Kapran, Y.
    Tanakol, R.
    Alagoel, F.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (08) : 537 - 543
  • [30] Cartilage-Hair Hypoplasia Syndrome: Increased Apoptosis of T Lymphocytes Is Associated with Altered Expression of Fas (CD95), FasL (CD95L), IAP, Bax, and Bcl2
    Leman Yel
    Sudeepta Aggarwal
    Sudhir Gupta
    Journal of Clinical Immunology, 1999, 19 : 428 - 434
12345